Exosomes from isobavachin-modified bone marrow mesenchymal stem cells promote osteoblast proliferation and alleviate osteoporosis by targeting the miR-127-3p/KIF3B/Wnt/β-catenin pathway
Archives of Biochemistry and Biophysics · 2026
DOI: 10.1016/j.abb.2025.110713 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2026. Verfasst von Yu Ning und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics and Traumatology, Xiangyang Hospital of Traditional Chinese Medicine Affiliated to Hubei University of Chinese Medicine (Xi…. Hauptthemen laut MEDLINE: Exosomes, MicroRNAs, Mesenchymal Stem Cells, Osteoblasts. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: Natural Science Foundation of Hubei Province.
Abstract (Originalsprache)
BACKGROUND: Mesenchymal stem cell-derived exosomes (MSC-exosome), a promising cell-free strategy, show attractive applications in the treatment of osteoporosis. Pretreatment of MSCs before application can effectively improve the therapeutic efficacy of MSC-exosomes. Our study investigated the effects of exosomes from isobavachin (IBA)-pretreated human bone marrow-derived MSCs (hBMSCIBA-exosomes) on osteoporosis progression and further unveil the underlying molecular mechanism. METHODS: hBMSCs were treated with IBA alone, transfected with miR-NC/miR-127-3p alone, or pre-treated with IBA and then transfected with NC inhibitor/miR-inhibitor, followed by the collection of exosomes. Human hFOB1.19 osteoblasts were co-cultured with hBMSC-exosomes, and osteoblast proliferation and differentiation were detected. The target gene of miR-127-3p was predicted using bioinformatic analysis and validated by dual-luciferase reporter assay. The KIF3B silencing vector (sh-KIF3B) and the Wnt/β-catenin pathway agonist LiCl were used to respectively validate the involvement of KIF3B and the Wnt/β-catenin pathway in the effects of exosomal miR-127-3p from IBA-treated hBMSCs on osteoblast proliferation and differentiation. Ovariectomy (OVX)-induced rat models of osteoporosis were injected with hBMSCIBA-exosomes. Their anti-osteoporotic and pro-osteogenic effects in vivo were confirmed through micro-CT analysis, histological examination, and detection of osteogenesis markers. RESULTS: IBA enhanced the promotive effects of hBMSC-exosomes on osteoblast proliferation and differentiation. IBA pretreatment upregulated miR-127-3p expression in hBMSCs and derived exosomes. Overexpressing exosomal miR-127-3p facilitated while downregulating exosomal miR-127-3p suppressed osteoblast proliferation and differentiation Mechanistically, miR-127-3p targeted KIF3B to facilitate the Wnt/β-catenin pathway. KIF3B silencing or LiCl pretreatment reversed the effects of exosomal miR-127-3p knockdown on osteoblast proliferation and differentiation. Additionally, IBA enhanced the anti-osteoporotic and pro-osteogenic effects of hBMSC-exosomes in osteoporosis rat models. However, inhibition of exosomal miR-127-3p abrogated the beneficial effects of hBMSCIBA-exosomes in osteoporotic rats. CONCLUSION: Exosomes derived from IBA-pretreated hBMSCs markedly stimulate osteogenesis and ameliorate osteoporosis by delivering miR-127-3p, which inhibits KIF3B and activates the Wnt/β-catenin pathway. Our results reveal the potential of IBA in improving the efficacy of hBMSC-exosomes in the treatment of osteoporosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics and Traumatology, Xiangyang Hospital of Traditional Chinese Medicine Affiliated to Hubei University of Chinese Medicine (Xiangyang Institute of Traditional Chinese Medicine), No.24 Changzheng R…
- Department of Orthopaedics, Wuhan Third Hospital, Tongren Hospital of Wuhan University, No.241 Pengliuyang Road, Wuchang District, Wuhan City, 430000, China.
- Department of Orthopedics and Traumatology, Hubei Provincial Hospital of Traditional Chinese Medicine, No.4 Huayuanshan, Wuchang District, Wuhan City, 430000, Hubei Province, China. Electronic address: Wweiwww@hotmail.c…
Förderung
- Natural Science Foundation of Hubei Province
Zitieren
APA
Ning, Y., Li, L., Liu, X., Xu, H., & Wang, W. (2026). Exosomes from isobavachin-modified bone marrow mesenchymal stem cells promote osteoblast proliferation and alleviate osteoporosis by targeting the miR-127-3p/KIF3B/Wnt/β-catenin pathway. Archives of Biochemistry and Biophysics. https://doi.org/10.1016/j.abb.2025.110713
Vancouver
Ning Y, Li L, Liu X, Xu H, Wang W. Exosomes from isobavachin-modified bone marrow mesenchymal stem cells promote osteoblast proliferation and alleviate osteoporosis by targeting the miR-127-3p/KIF3B/Wnt/β-catenin pathway. Archives of Biochemistry and Biophysics. 2026. doi:10.1016/j.abb.2025.110713
BibTeX
@article{Ning2026,
author = {Ning, Yu and Li, Luanning and Liu, Xiangzhong and Xu, Haijia and Wang, Wei},
title = {Exosomes from isobavachin-modified bone marrow mesenchymal stem cells promote osteoblast proliferation and alleviate osteoporosis by targeting the miR-127-3p/KIF3B/Wnt/β-catenin pathway},
journal = {Archives of Biochemistry and Biophysics},
year = {2026},
doi = {10.1016/j.abb.2025.110713}
}
EUVIMED